Plasma, guidelines, and evidence-based medicine

Blood Transfusion

Volumn 6, Issue 1, 2008, Pages 3-5

  Reverberi, Roberto ^a,b  

^a Azienda Ospedaliera Universitaria di Ferrara   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CLINICAL PRACTICE; EDITORIAL; EVIDENCE BASED PRACTICE; INFORMATION RETRIEVAL; PLASMA; PRACTICE GUIDELINE;

BLOOD COMPONENT TRANSFUSION; EVIDENCE-BASED MEDICINE; HUMANS; PLASMA; PRACTICE GUIDELINES AS TOPIC;

EID: 47749108311     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2008.0052-07     Document Type: Editorial

References (18)

1. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992; 268: 2420-5.
2. Kuhn TS. The structure of scientific revolutions. Chicago, Ill. 1970. University of Chicago Press.
3. Sackett DL, Rosenberg WMC, Gray JAM, et al. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-2.
4. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281: 1900-5.
5. Cluzeau FA, Littlejohns P, Grimshaw JM, et al. Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care 1999; 11: 21-8.
6. The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003; 12; 18-23.
7. Minhas R. Eminence-based guidelines: a quality assessment of the second Joint British Societies' guidelines on the prevention of cardiovascular disease. Int J Clin Pract 2007; 61: 1137-44.
8. Wright JM. Practice guidelines by specialist societies are surprisingly deficient. Int J Clin Pract 2007; 61: 1076-7.
9. Iorio A, Basileo M, Marchesini E et al. The good use of plasma. A critical analysis of the main international guidelines. Blood Transfus 2008; 6: 18-24.
10. Liumbruno GM, Sodini ML, Grazzini G. Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma. Blood Transfus 2008; 6: 25-36.
11. http://www.agreecollaboration.org.
12. http://www.agreecollaboration.org/pdf/aitraining.pdf.
13. Horowitz B, Lazo A, Grossberg H, et al. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma. Vox Sang 1998; 74 Suppl 1: 203-6.
14. Yarranton H, Cohen H, Pavord SR, et al. Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol 2003; 121: 778-85.
15. de Jonge J, Groenland TH, Metselaar HJ, et al. Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP). Anesth Analg 2002; 94: 1127-31.
16. Magner JJ, Crowley KJ, Boylan JF. Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas). J Cardiothorac Vasc Anesth 2007; 21: 410-3.
17. Doyle S, O'Brien P, Murphy K, Fleming C, O'Donnell J. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 2003; 14: 283-7.
18. Coignard BP, Nguyen GT, Tokars J et al. A cluster of intra-operative deaths in a liver transplant centre associated with the use of solvent/detergent plasma. California, 2000. In: Abstracts, SHEA, 11th Annual Meeting. Mt. Royal (NJ): Society for Healthcare Epidemiology of America; 2001.